Henry Ford Health

Henry Ford Health Scholarly Commons
Dermatology Articles

Dermatology

11-18-2020

Principles for developing and adapting clinical practice guidelines
and guidance for pandemics, wars, shortages, and other crises
and emergencies: the PAGE criteria
Murad Alam
Vishnu Harikumar
Sarah A. Ibrahim
Bianca Y. Kang
Ian A. Maher

See next page for additional authors

Follow this and additional works at: https://scholarlycommons.henryford.com/dermatology_articles

Recommended Citation
Alam M, Harikumar V, Ibrahim SA, Kang BY, Maher IA, Cartee TV, Sobanko JF, Kibbi N, Owen JL, Reynolds
KA, Bolotin D, Waldman AH, Minkis K, Petersen B, Council ML, Nehal KS, Xu YG, Jiang SB, Somani AK,
Bichakjian CK, Huang CC, Eisen DB, Ozog DM, Lee EH, Samie FH, Neuhaus IM, Bordeaux JS, Wang JV,
Leitenberger JJ, Mann MW, Lawrence N, Zeitouni NC, Golda N, Behshad R, Ibrahim SF, Yu SS, Shin TM,
Stebbins WG, and Worley B. Principles for developing and adapting clinical practice guidelines and
guidance for pandemics, wars, shortages, and other crises and emergencies: the PAGE criteria. Arch
Dermatol Res 2020.

This Article is brought to you for free and open access by the Dermatology at Henry Ford Health Scholarly
Commons. It has been accepted for inclusion in Dermatology Articles by an authorized administrator of Henry Ford
Health Scholarly Commons.

Authors
Murad Alam, Vishnu Harikumar, Sarah A. Ibrahim, Bianca Y. Kang, Ian A. Maher, Todd V. Cartee, Joseph F.
Sobanko, Nour Kibbi, Joshua L. Owen, Kelly A. Reynolds, Diana Bolotin, Abigail H. Waldman, Kira Minkis,
Brian Petersen, M. Laurin Council, Kishwer S. Nehal, Y. Gloria Xu, S. Brian Jiang, Ally-Khan Somani,
Christopher K. Bichakjian, Conway C. Huang, Daniel B. Eisen, David M. Ozog, Erica H. Lee, Faramarz H.
Samie, Isaac M. Neuhaus, Jeremy S. Bordeaux, Jordan V. Wang, Justin J. Leitenberger, Margaret W. Mann,
Naomi Lawrence, Nathalie C. Zeitouni, Nicholas Golda, Ramona Behshad, Sherrif F. Ibrahim, Siegrid S. Yu,
Thuzar M. Shin, William G. Stebbins, and Brandon Worley

This article is available at Henry Ford Health Scholarly Commons: https://scholarlycommons.henryford.com/
dermatology_articles/497

Archives of Dermatological Research
https://doi.org/10.1007/s00403-020-02167-x

CONCISE COMMUNICATION

Principles for developing and adapting clinical practice guidelines
and guidance for pandemics, wars, shortages, and other crises
and emergencies: the PAGE criteria
Murad Alam1 · Vishnu Harikumar1 · Sarah A. Ibrahim1 · Bianca Y. Kang1 · Ian A. Maher2 · Todd V. Cartee3 ·
Joseph F. Sobanko4 · Nour Kibbi5 · Joshua L. Owen1,31 · Kelly A. Reynolds1 · Diana Bolotin6 · Abigail H. Waldman7 ·
Kira Minkis8 · Brian Petersen9 · M. Laurin Council10 · Kishwer S. Nehal11 · Y. Gloria Xu12 · S. Brian Jiang13 ·
Ally‑Khan Somani14 · Christopher K. Bichakjian15 · Conway C. Huang16 · Daniel B. Eisen17 · David M. Ozog18 ·
Erica H. Lee11 · Faramarz H. Samie19 · Isaac M. Neuhaus20 · Jeremy S. Bordeaux21,22 · Jordan V. Wang23 ·
Justin J. Leitenberger24 · Margaret W. Mann21,22 · Naomi Lawrence25 · Nathalie C. Zeitouni26 · Nicholas Golda27 ·
Ramona Behshad28 · Sherrif F. Ibrahim29 · Siegrid S. Yu20 · Thuzar M. Shin4 · William G. Stebbins30 · Brandon Worley1
Received: 14 October 2020 / Revised: 30 October 2020 / Accepted: 3 November 2020
© Springer-Verlag GmbH Germany, part of Springer Nature 2020

In recent years, the development of clinical practice guidelines has become a more formalized and ubiquitous process.
The AGREE II [1, 2] and RIGHT [3] paradigms provide
instruction for reporting guidelines development; GRADE
[4] and other systems have been refined for assessing the
level of evidence and qualifying the strength of recommendations. Nationally recognized authorities such as the NCCN
[5], professional medical societies with guidelines committees [6, 7], interdisciplinary working groups, the National
Guidelines Clearinghouse [8] and successor organizations
are all playing key roles in developing and disseminating
guidelines.
The reasons for guideline development are many. Given
the increased interest in quality of care, guidelines can be
helpful for educating providers about best practices and
decreasing variation in care delivery. Guidelines can also
help introduce new therapies or diagnostic interventions, and
clarify their role in patient management. Guidelines for rare
conditions or diseases can spark interest in them and illuminate areas where knowledge is lacking, thereby stimulating
further research. When high-level evidence is lacking but
providers need direction, guidelines based largely on expert
opinion can fill the gap. Payers and regulators can also look
to guidelines to better understand the standard of care, even
though guidelines documents typically include a disclaimer
specifically disavowing any intent to create or reinforce such
a standard. Even patients can benefit from guidelines, which
* Murad Alam
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may help them learn about their condition and its common
management options.
Clinical practice guidelines are general documents
designed to apply to most affected patients in commonly
encountered clinical situations. While certain special circumstances may be envisioned, guidelines are not usually
intended for situations in which normal care delivery is
interrupted. Thus, at present, there is a need for a template for the adaptation of clinical practice guidelines to
widespread emergency situations not specifically related
to the disease or condition addressed by the guidelines.
Relevant emergencies may be local, regional, national, or
international. The precise nature of an emergency may
vary, with possibilities including epidemics or pandemics,
wars, shortages of medical services or products, natural
disasters (e.g., earthquakes, fires, floods, droughts), and
others. The common feature of such emergencies is an
inability to provide routine care to patients because of
effects on patients, effects on the health care system, or
both.
The following is a template for the creation of adapted
emergency guidance associated with existing clinical
practice guidelines. This template (PAGE, Principles for
Adapting Guidelines in Emergencies) is the product of
the CISTERN (Committee on Invasive Tumor EvidenceBased Recommendations) [9, 10] group, a multidisciplinary, multispecialty collaboration formed for the purpose
of cancer guidelines development. The template was
developed during consensus meetings during March and
April 2020.
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General rules for emergency guidance
Adapted guidance can be helpful during emergencies and
times of uncertainty when the normal conditions of care
delivery are disrupted. Common criteria may facilitate the
development of any emergency guidance:
(1) Plan a short timeline to completion. Since an
emergency implies problematic circumstances that
are unexpected, patients and providers will not have
planned for the scenario and will need prompt guidance on how to proceed. Whether a draft guideline is
needed in hours, days, or weeks, will depend on the
nature of the specific emergency. Consider contacting other experts to develop the appropriate timeline
before proceeding. To increase the likelihood that this
timeline will be observed, it may be prudent to obtain,
at the inception of the process, written commitments
from participants to hew to it, and devote appropriate time; those that are unwilling or unable may need
to be substituted with experts having comparable
knowledge. Upon invitation, each participant may be
furnished with a calendar listing dates and times for
all subsequent meetings, virtual or otherwise, either
of the entire group or its various subgroups. This will
help participants prepare, and also facilitate on-time
completion of the guidelines.
(2) Consider limited guidance rather than full guidelines. The specific emergency likely impacts only
part of the care delivery process for a particular disease or condition, and so the emergency direction
should be limited in scope. There will not be the
time, resources, or necessity for rigorous guidelines
development. Instead, emergency guidance can be
framed as a quick, best-guess, partial solution for a
pressing problem. Though the best available evidence
should drive any recommendations, emergency guidance may rely heavily on expert opinion. It is unlikely
new high-quality studies will be available. Guidance
should be qualified to make clear to the reader that the
standard processes for guidelines development were
either abbreviated or not followed, and as a result, the
guidance provided is inherently less robust and more
provisional.
(3) Define the conditions during which the guidance
will be in effect. By definition, emergency guidance
is predicated on the existence of an emergency. While
the nature of the emergency may be self-evident to
those preparing the guidance, it is important that the
relevant conditions prompting the new rules to be
clearly and precisely delineated in writing to avoid
any ambiguity. This will preclude any misunderstand-
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(4)

(5)

(6)

(7)

ing that the emergency guidance is in fact new blanket
guidance that is always operative. Moreover, characterizing the specific conditions of the emergency, and
the rationale for the emergency guidance, will also
make it clear when the emergency comes to an end,
and the emergency guidance ceases to apply. If the
end date of an emergency is known at the time the
emergency guidance is prepared, this date should be
included in the emergency document as the date of
expiration.
Explain how the group developing the guidelines
was assembled, and use an existing guidelines
group, if possible. Many professional medical societies have standing guidelines committees that can be
mobilized expeditiously. Other national guidelines
groups may also be well-poised to respond to emergencies. In general, it will be more effective to ask
members of an existing group to work together to
develop emergency guidelines than to try to convene
a new group, as the latter will take time to assemble
and train. If the expertise within an existing guidelines
group is insufficient, ad hoc members may be added
as necessary.
Use a guidelines group of sufficient size. Since emergency guidance will likely be heavily supported by
expert opinion rather than high-level published evidence, it is important that the group be of sufficient
size and diversity to ensure that its recommendations
are viewed as credible. A small or homogeneously
constituted group may be viewed as excessively
swayed by the opinions of individual members, even
if such bias is inadvertent or unconscious.
Avoid duplication of the work of other guidelines
groups. Several different guidelines groups may be
poised to develop emergency guidance on the same
topic. Coordination between these groups, if known to
each other, is best while the others tacitly endorse its
work product. Multiple, competing sets of dissimilar
guidances may exacerbate confusion among patients
and providers.
Only adopt recommendations supported by consensus or at least a supermajority. When providing
guidance resting almost solely on expert opinion, it is
particularly important that this opinion be perceived
as widely shared. If an existing group is being mobilized to develop emergency guidelines, reasonable
efforts should be undertaken to include all members
of this group, as well as other ad hoc invitees with
relevant expertise. Group consensus is best, but if it
is unachievable, any recommendations should be supported by at least a 60% (3/5th) supermajority of all
group members. Anonymity may be preserved, but a

Archives of Dermatological Research

(8)

(9)

(10)

(11)

complete vote count (i.e., total number of group members, votes in favor, votes against, and abstentions)
should be posted next to each recommendation. A
brief rationale shared by those in favor of the recommendation should also be included.
Convey the tenor and degree of support of dissenting views. While views supported by a single
group member or a very small subgroup need not be
divulged, dissenting recommendations supported by
a sizable minority (20% or more) of the group should
be summarized in the guidance after the majority recommendation. This is not to detract from the majority recommendations but to concede that a degree of
uncertainty exists.
Areas of uncertainty should be acknowledged, and
issues regarding which no recommendations can be
provided should be noted. There may be important
concerns pertaining to the emergency for which no
clear guidance can be provided due to a very high
level of associated uncertainty. If this occurs, the
relevant concerns should be discussed in the guidance document and the lack of agreement regarding
their management should be explicitly stated. If one
or more sizable minorities of the group have views
regarding the management of these concerns, these
minority opinions and the proportion of the group
supporting each may be briefly conveyed.
Do not promulgate recommendations outside the
specific scope of the guidelines group. Emergencies may arise due to natural or man-made disasters,
pandemics or pestilence, market forces and market
failures (e.g., shortages), and civil disobedience
or armed conflict between nations. Doctors are not
experts in natural disasters, terrorism, economics, or
warfare. Indeed, members of a guidelines group will
lack expertise even in unrelated medical specialties or
subspecialties. For these reasons, guidance prepared
by physicians to manage specific diseases and conditions in the context of emergencies should not venture
into speculating about the nature, causes, duration, or
course of the underlying emergencies. If it is important to discuss safety measures recommended by other
authorities to cope with the underlying emergency, the
relevant authorities should be referenced or outside
consultation sought. Citing appropriate references or
linking to a webpage may be preferable to attempting
to reproduce general third-party guidance in a diseasespecific guidance document. By referencing other
authorities, the guidelines group will avoid inadvertently providing wrong or outdated recommendations.
Ensure that the final document is brief and easy
to read. Since emergency guidance is an adaptation
of existing guidelines, it does not need to be long

or complex. Apart from the elements that must be
included (e.g., recommendations, rationale for recommendations, dissenting views, areas of uncertainty),
the details of the deliberations leading to specific
recommendations should be omitted or relegated to
footnotes.
(12) Widely disseminate the emergency guidance document. Patients and physicians may be distracted in
an emergency situation. Since they may be inundated
with information excess related to the emergency, they
may not be aware of the existence of recently produced emergency guidance. The emergency guidance
document should thus be proactively disseminated by
the guidelines group to relevant physicians and caregivers through as many communications channels as
possible. For instance, the emergency guidance may
be: emailed to caregivers; physically mailed to caregivers, if appropriate; presented from the podium at
live meetings or teleconferences attended by medical
professionals; sent to professional medical societies
for posting on their web-pages and for inclusion in
their news feeds; submitted for expedited publication
to peer-reviewed journals; and abstracted in non-peer
reviewed trade publications. Emergency guidance is
only useful to the extent that it is implemented by
physicians providing relevant care, and physicians can
only implement guidance that is readily available, or
easy to find or download.
(13) Update the guidance as often as necessary. Emergencies emerge unexpectedly, and they also evolve.
If conditions associated with an emergency change
materially, existing emergency guidance may need to
be updated. Updates should be marked with the time
and date when they were adopted. Updates should also
be available in the same repository as all preceding
guidance and updates, so it is clear to readers which
is the most recent guidance. If email or other contact information is available for users of the original
guidance or previous updates, future updates should
automatically be sent to those to ensure they are not
unwittingly relying on outdated guidance. After the
crisis has ended, revisit key guidelines to update the
relevant disaster planning sections to include the lessons learned from the event.

Special considerations based on the type
of emergency
As noted care-disrupting emergencies can occur when there
is: damage to physical locations where care is provided; a
shortage of drugs or devices; a shortage of qualified personnel; an excessive number of patients needing care; a situation
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in which patients are under physical threat or cannot safely
present to receive care; or a situation in which providers are
under physical threat or cannot safely deliver care.
Next, we consider specific rules that may help with
developing emergency guidance in particular types of
emergencies. For each of these types of emergencies, only
recommendations specific to the disease or condition being
considered need be provided in the guidance document.
Defer to local, state, or national emergency management
authorities for general guidance on healthcare delivery in
the context of the emergency.
(1) Damage to physical location, like hospital buildings:
If appropriate, the emergency guidance document may
explain how appropriate care for the disease or condition may need to be delivered in non-medical buildings,
temporary shelters, or at home.
(2) Shortage of drugs or devices: If appropriate, provide
suggestions for substituting other drugs or devices for
managing the disease or condition. For devices, if the
relevant technical expertise exists among the guidelines
group, consider designing new, minimally resourceintensive, and easy-to-fabricate substitutes that may
be rapidly manufactured.
(3) Shortage of qualified personnel: If appropriate, provide methods for efficiently training other medical
personnel to perform the necessary functions for the
disease or condition. Specify what types of personnel
and which types of pre-existing job functions may be
most suitable for retraining.
(4) An excessive number of patients needing care: If
appropriate, triage patients to minimize overall morbidity and mortality based on a risk assessment of the
condition or disease and its relevant subcategories.
Also, identify means that can be used to speed treatment for the disease or condition or to make treatment
less resource-intensive. Avoid discussion about rationing care or withholding care from more vulnerable subpopulations as this is an ethically problematic topic for
physicians.
(5) A situation in which patients are under physical
threat or cannot safely present to receive care: If
appropriate, describe alternative strategies for treating
the disease or condition, including telemedicine, home
visits, or public health initiatives.
(6) A situation in which providers are under physical
threat or cannot safely deliver care: If appropriate,
describe alternative strategies for treating the disease
or condition, including telemedicine or public health
initiatives. Referral to a provider in another location
may be preferable. If traveling by providers is infeasible, consider developing methods for training local
caregivers or family members.
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Emergency provisions of general
(non‑emergency) clinical practice guidelines
While emergency guidance may be necessary, preparing this
is likely to be resource-intensive and associated with delay.
Development of even the most efficiently produced emergency guidance will be preceded by the recognition of the
need for such, assembly of the guidelines group, a consensus
estimate of how the emergency should alter care delivery,
and writing and dissemination of the guidance document.
To mitigate the need for a separate emergency guidance
document, creators of general (non-emergency) clinical
guidelines may include a section describing how the main
guidelines may be adapted in an emergency situation. Since
the particular type of emergency will not be known at the
time, this section may stratify potential emergency strategies based on the risk level associated with the emergency.
In other words, in a dire emergency in which it is extremely
difficult to deliver care safely, only the care most crucial for
patients may be provided. In a less extreme emergency, other
types of care may be feasible.
In summary, emergency guidelines for clinical care of
particular diseases or conditions may become necessary.
When possible, advanced planning and anticipatory strategies can be developed to allow for a rapid response. If this
occurs, abbreviated guidance may be promptly developed
that is focused specifically on the exigencies of treating this
disease or condition given the emergency-associated limitations. Such guidance may be most efficiently prepared by
an existing guidelines group, assuming the group is large
enough to be viewed as sufficiently diverse and unbiased.
Vote tallies in favor of individual recommendations should
be noted in the guidance document, with the views of sizable
minorities also conveyed. Areas of uncertainty should be
acknowledged. Specific types of emergencies may warrant
additional types of specific medical guidance. In all circumstances, emergency guidance provided by physicians with
expertise in a narrow field should avoid advising patients on
managing the greater emergency.
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